PreveCeutical Financial Statements From 2010 to 2025

PRVCF Stock  USD 0.02  0  9.76%   
PreveCeutical Medical financial statements provide useful quarterly and yearly information to potential PreveCeutical Medical investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on PreveCeutical Medical financial statements helps investors assess PreveCeutical Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting PreveCeutical Medical's valuation are summarized below:
PreveCeutical Medical does not presently have any trending fundamental ratios for analysis.
Check PreveCeutical Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PreveCeutical Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . PreveCeutical financial statements analysis is a perfect complement when working with PreveCeutical Medical Valuation or Volatility modules.
  
This module can also supplement various PreveCeutical Medical Technical models . Check out the analysis of PreveCeutical Medical Correlation against competitors.

PreveCeutical Medical OTC Stock Return On Asset Analysis

PreveCeutical Medical's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current PreveCeutical Medical Return On Asset

    
  -3.31  
Most of PreveCeutical Medical's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PreveCeutical Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, PreveCeutical Medical has a Return On Asset of -3.3124. This is 62.14% lower than that of the Healthcare sector and 85.96% lower than that of the Biotechnology industry. The return on asset for all United States stocks is notably higher than that of the company.

PreveCeutical Medical Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining PreveCeutical Medical's current stock value. Our valuation model uses many indicators to compare PreveCeutical Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PreveCeutical Medical competition to find correlations between indicators driving PreveCeutical Medical's intrinsic value. More Info.
PreveCeutical Medical is considered to be number one stock in return on asset category among its peers. It also is rated top company in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PreveCeutical Medical's earnings, one of the primary drivers of an investment's value.

About PreveCeutical Medical Financial Statements

PreveCeutical Medical stakeholders use historical fundamental indicators, such as PreveCeutical Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although PreveCeutical Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in PreveCeutical Medical's assets and liabilities are reflected in the revenues and expenses on PreveCeutical Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in PreveCeutical Medical. Please read more on our technical analysis and fundamental analysis pages.
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada. Preveceutical Medical operates under Biotechnology classification in the United States and is traded on OTC Exchange.

Currently Active Assets on Macroaxis

Other Information on Investing in PreveCeutical OTC Stock

PreveCeutical Medical financial ratios help investors to determine whether PreveCeutical OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PreveCeutical with respect to the benefits of owning PreveCeutical Medical security.